These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4155235)

  • 1. The "on-off" effect.
    Carlsson A
    Adv Neurol; 1974; 5():367-8. PubMed ID: 4155235
    [No Abstract]   [Full Text] [Related]  

  • 2. Variations in the "on-off" phenomenon.
    Duvoisin RC
    Adv Neurol; 1974; 5():339-40. PubMed ID: 4440582
    [No Abstract]   [Full Text] [Related]  

  • 3. The "on-off" response to chronic L-DOPA treatment of Parkinsonism.
    Sweet RD; McDowell FH
    Adv Neurol; 1974; 5():331-8. PubMed ID: 4440581
    [No Abstract]   [Full Text] [Related]  

  • 4. The "on-off" side effect of L-DOPA.
    Markham CH
    Adv Neurol; 1974; 5():387-96. PubMed ID: 4440586
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma levodopa and the "on-off" effect.
    Caine DB; Claveria LE; Allen JG
    Adv Neurol; 1974; 5():341-4. PubMed ID: 4440583
    [No Abstract]   [Full Text] [Related]  

  • 6. Variations in the "on-off" effect.
    Yahr MD
    Adv Neurol; 1974; 5():397-9. PubMed ID: 4440587
    [No Abstract]   [Full Text] [Related]  

  • 7. L-dopa, parkinsonism, and involuntary movements.
    Mayer RF
    Trans Am Neurol Assoc; 1974; 99():163-6. PubMed ID: 4463527
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biochemical bases of Parkinson disease].
    Colucci d'Amato C; Puccini A; Cristillo A; Vizioli R
    Recenti Prog Med; 1984 Oct; 75(10):889-901. PubMed ID: 6151219
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of lithium on the "on-off" phenomenon in parkinsonism.
    Coffey CE; Ross DR; Ferren EL; Bragdon AC; Hurwitz BJ; Olanow CW
    Adv Neurol; 1983; 37():61-73. PubMed ID: 6858779
    [No Abstract]   [Full Text] [Related]  

  • 10. [Problems in the administration of L-DOPA (author's transl)].
    Ferrari E
    Riv Patol Nerv Ment; 1974 Aug; 95(4):239-50. PubMed ID: 4283417
    [No Abstract]   [Full Text] [Related]  

  • 11. Short- and long-term approaches to the "on-off" phenomenon.
    Papavasiliou PS; Cotzias GC; Mena I
    Adv Neurol; 1974; 5():379-86. PubMed ID: 4440585
    [No Abstract]   [Full Text] [Related]  

  • 12. [Parkinson's disease].
    Nagatsu T
    Tanpakushitsu Kakusan Koso; 1984 Dec; 29(14):1801-14. PubMed ID: 6152497
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results after 3 to 5 years of treatment of 219 cases of Parkinson's syndrome treated by L-Dopa and an L-Dopa -decarboxylase inhibitor combination].
    Boudin G; Pepin B; Guillard A; Godlewski S; Fabiani JM; Haguenau M
    Rev Neurol (Paris); 1974; 130(7-8):273-84. PubMed ID: 4217929
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimentally induced parkinsonism.
    Poirier LJ; Sourkes TL
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():416-33. PubMed ID: 4403656
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aspects of long-term treatment with levodopa alone and levodopa combined with dopa decarboxylase inhibitors].
    Cinca I; Serbănescu A; Tudorache B
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(4):261-70. PubMed ID: 6222452
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma dopa concentrations and the "on-off" effect after chronic treatment of Parkinson's disease.
    Sweet RD; McDowell FH
    Neurology; 1974 Oct; 24(10):953-6. PubMed ID: 4472237
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical physiology of side effects in long-term L-DOPA therapy.
    Barbeau A
    Adv Neurol; 1974; 5():347-365. PubMed ID: 4155234
    [No Abstract]   [Full Text] [Related]  

  • 18. Parkinsonism and its treatment.
    Strouthidis TM
    Nurs Mirror Midwives J; 1974 Sep; 139(12):44-8. PubMed ID: 4610518
    [No Abstract]   [Full Text] [Related]  

  • 19. On-off effects in Parkinson's disease: a controlled investigation of ascorbic acid therapy.
    Reilly DK; Hershey L; Rivera-Calimlim L; Shoulson I
    Adv Neurol; 1983; 37():51-60. PubMed ID: 6344591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of dyskinesias.
    Mov Disord; 1990; 5(3):265-6. PubMed ID: 2388648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.